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Abstract
Signalling lymphocyte activation molecule (SLAM) has been identified as an immune cell receptor for the morbilliviruses,
measles (MV), canine distemper (CDV), rinderpest and peste des petits ruminants (PPRV) viruses, while CD46 is a receptor for
vaccine strains of MV. More recently poliovirus like receptor 4 (PVRL4), also known as nectin 4, has been identified as a
receptor for MV, CDV and PPRV on the basolateral surface of polarised epithelial cells. PVRL4 is also up-regulated by MV in
human brain endothelial cells. Utilisation of PVRL4 as a receptor by phocine distemper virus (PDV) remains to be
demonstrated as well as confirmation of use of SLAM. We have observed that unlike wild type (wt) MV or wtCDV, wtPDV
strains replicate in African green monkey kidney Vero cells without prior adaptation, suggesting the use of a further
receptor. We therefore examined candidate molecules, glycosaminoglycans (GAG) and the tetraspan proteins, integrin b
and the membrane bound form of heparin binding epithelial growth factor (proHB-EGF),for receptor usage by wtPDV in
Vero cells. We show that wtPDV replicates in Chinese hamster ovary (CHO) cells expressing SLAM and PVRL4. Similar wtPDV
titres are produced in Vero and VeroSLAM cells but more limited fusion occurs in the latter. Infection of Vero cells was not
inhibited by anti-CD46 antibody. Removal/disruption of GAG decreased fusion but not the titre of virus. Treatment with
anti-integrin b antibody increased rather than decreased infection of Vero cells by wtPDV. However, infection was inhibited
by antibody to HB-EGF and the virus replicated in CHO-proHB-EGF cells, indicating use of this molecule as a receptor.
Common use of SLAM and PVRL4 by morbilliviruses increases the possibility of cross-species infection. Lack of a
requirement for wtPDV adaptation to Vero cells raises the possibility of usage of proHB-EGF as a receptor in vivo but
requires further investigation.
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Introduction
Morbilliviruses constitute a genus within the family Paramyx-
oviridae, subfamily Paramyxovirinae. Members of the genus
include measles virus (MV), canine distemper virus (CDV),
rinderpest virus (RPV), peste des petits ruminants virus (PPRV)
and the more recently identified marine morbilliviruses, phocine
distemper virus (PDV), dolphin morbillivirus (DMV) and porpoise
morbillivirus (PMV). DMV and PMV are now considered a single
species of cetacean virus. Due to the close sequence similarity and
cross-species infection PDV is thought to be derived from CDV
through contact between terrestrial carnivores and seals [1].
The expression of specific viral receptors on the host cell surface
is a prerequisite for virus entry and is a major determinant of tissue
tropism and viral pathogenesis. There is a concern that once MV
is eradicated and vaccination discontinued that one or more of the
veterinary morbillivirus could cross species into humans as is
thought to have occurred in the past. Phylogenetic evidence
suggests that MV may have evolved from RPV following
domestication of cattle [2]. There is a new threat as in recent
years CDV has caused outbreaks in non-human primates [3–5].
Studies in dogs and non-human primates indicate that continuing
vaccination after eradication of MV is likely to provide a sufficient
degree of cross-protection to protect humans against other
morbilliviruses [6,7]. However, it is important to determine the
use of common or unique cell entry receptors across the
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morbillivirus genus as an indicator of cross-species infection
potential.
The hemagglutinin (H) and fusion (F) proteins of morbilliviruses
are responsible for attachment to and fusion with the host cell
plasma membrane, respectively and therefore the expression of
both proteins is necessary for efficient cell entry [8]. Morbillivi-
ruses infect a number of different cell types in vivo including
leucocytes, epithelial, endothelial and neural cells with the need for
more than one receptor type [9].
Signalling lymphocyte activation molecule (SLAM) or CD150 is
a member of the C2 subset of the immunoglobulin superfamily
and is expressed on activated B and T cells, constitutively on
immature thymocytes, memory T cells, a proportion of B cells as
well as activated monocytes and mature dendritic cells [10–12].
SLAM has been identified as a receptor for both vaccine and wild
type (wt) strains of MV as well as for CDV, RPV and PPRV [13–
16]. The immune cell types infected are predominantly T, B and
dendritic cells [17–19] and morbilliviruses have been found to use
SLAM of non-host species but with lower efficiency [14]. Vero
cells expressing canine SLAM have been used to isolate wtPDV
[20,21] as it has been assumed that PDV uses this receptor but this
has not been confirmed.
Molecules other than SLAM must mediate virus cell entry in
other cell types such as epithelial, endothelial and neural cells.
More recently PVRL4 (also known as nectin 4) has been identified
as a receptor for MV [22,23], CDV [24] and PPRV [16] on the
basal surface of epithelial cells. We have also shown that PVRL4 is
up-regulated in human brain endothelial cells by MV infection
[25]. It is not known if PDV also uses this receptor.
CD46 (membrane cofactor protein), a type 1 transmembrane
glycoprotein and a complement regulatory protein, found on all
nucleated cells, was first identified as a MV receptor [26,27];
however, it was later shown that most wtMV strains did not
interact with CD46 [28,29]. CD46 is not a receptor for CDV and
RPV [30,31]. However, there is evidence to suggest that CDV-H
protein interacts with an unknown cellular receptor(s) regulated by
CD9, a member of the tetraspan transmembrane- protein family
[32]. Most tetraspans including CD9, associate with b1 integrins in
the cell membrane [33]. Furthermore, CD46 has been shown to
form a complex with CD9, beta1 integrins and the membrane
bound form of heparin-binding EGF-like growth factor (pro-HB-
EGF) [34,35]. HB-EGF and proHB-EGF have a highly conserved
heparin binding domain which is also the site of CD9 binding
[36]. Therefore, investigation of both beta1 integrins and pro-HB-
EGF as possible receptor molecules is of interest.
Other receptors for MV may act at the attachment stage but do
not allow virus entry. The C-type lectin DC-specific intercellular
adhesion molecule 3-grabbing nonintegrin DC-SIGN has been
shown to be an attachment receptor to enhance CD46/CD150-
mediated infection of Dendritic cells. The ligands for DC-SIGN
are both MV glycoproteins F and H in contrast to CD46, SLAM
and PVRL4 where only H is required [37]. In addition, human
primary Langerin cells (a subset of DCs) are capable of capturing
MV through the C-type lectin Langerin [38]. Glycosaminoglycans
(GAG) have been shown to have a role in infection by a tissue
culture-adapted vaccine strain of RPV and recombinant wt strains
of CDV as well as MV [15;39,40]. It has been suggested that GAG
which are ubiquitously expressed may not cause viral entry but
may support the binding of virus to a low affinity or low quantity
receptor [40].
In this study we investigated the use of CD46, SLAM and
PVRL4 as receptors for wtPDV and examined the interaction of
selected morbilliviruses with other candidate molecules, b1
integrin, pro-HB-EGF and GAG.
Materials and Methods
Cell lines and viruses
Vero-dogSLAM (VDS) cells were obtained from R. Cattaneo,
(Mayo Clinic, USA); B95a (an Epstein Barr virus-transformed
marmoset B cell line), Chinese Hamster Ovary (CHO), CHO-
CD46 and CHO-marmosetSLAM (CHO-MSLAM) cell lines
from J. Schneider-Schaulies (University of Wu¨rzburg, Germany);
CHO-dogSLAM (CHO-DSLAM) cells from V. von Messeling
(Mayo Clinic, USA); CHO-humanPVRL4 cells, which lack
heparin and chondroitin sulfate on their surface, from C.
Richardson (Dalhousie University, Halifax, Canada). CHO empty
plasmid (CHO-E) and CHO-human proHB-EGF cell lines were
obtained from R. Adam (Harvard University, USA). Vero and
VDS cells were grown in Dulbecco’s Modified Eagles Medium
containing 4500 mg/L glucose supplemented with 5% foetal calf
serum (FCS). VDS cells had 1 mg/ml zeocin (Invitrogen, USA)
added for selection of plasmid containing cells. B95a cells were
grown in RPMI-1640 medium supplemented with 10% FCS.
CHO, CHO-CD46 and CHO-SLAM cell lines were grown in
Dulbecco’s Modified Eagles Medium containing 4500 mg/L
glucose supplemented with 5% FCS and 1 mg/ml zeocin
(Invitrogen).CHO-PVRL4, CHO-proHB-EGF, CHO-E cells
were grown as for the other CHO cell lines except 1 mg/ml
geneticin (Invitrogen, USA) was used instead of zeocin for
selection of plasmid containing cells. Cells were incubated at
37uC with 5% (v/v) CO2. The origin of cell lines and the known
morbillivirus receptors on each of these are shown in Table 1.
WtPDV isolates PDV/NL88n and PDV/USA2006 [21], MV
Schwarz GFP [41], wtMV Dublin-3267 strain [42], the Edmon-
ston strain of MV, the Snyder Hill wtCDV strain (obtained from
M. Appel, Cornell University, USA) and the Onderstepoort strain
of CDV were grown and titred by TCID50 in VDS cells. The
origin and cell passage history of the viruses are shown in Table 2.
Unless otherwise stated all infections were carried out at a
multiplicity of infection (MOI) of 0.1.
Growth Curves
Triplicate cultures in 24 well trays were infected at an MOI of
0.1 for 1 hour. Cultures were washed 6 times to remove non
adsorbed virus and replaced with 1 ml of fresh maintenance
medium supplemented with 2% foetal calf serum (FCS). Total
virus was harvested from each well at selected time points and
titrated in VDS cells.
Sodium chlorate treatment
Cultures were grown for 48 h in 30 or 60 mM sodium chlorate.
The medium was removed and cells were washed twice in PBS,
infected as previously described and incubated with or without the
respective concentration of sodium chlorate.
Heparinase treatment
Vero cells were washed twice with PBS prior to incubation with
10 U/ml of Heparinase 1 (Sigma) and incubation at 37uC for
90 min. Cells were washed twice before infection. as previously
described.
Immunofluorescence
Cover slip cultures were fixed in 4% paraformaldehyde. Where
intracellular staining for virus was required cells were permeabi-
lised with Triton-X 100 (Sigma) and fixed before staining. For
receptors, cells were not permeabilised and fixation was carried
out after staining. Cells were initially incubated with blocking
solution (0.5% bovine serum albumin in PBS). Following removal
Cell Entry Receptors for Wild Type Phocine Distemper Virus
PLOS ONE | www.plosone.org 2 August 2014 | Volume 9 | Issue 8 | e106281
of blocking solution, cover slips were incubated for 1 hr at 37uC
with appropriate primary antibodies or control serum diluted in
blocking solution: Serum obtained from a patient with subacute
scelerosing panencephalitis (SSPE, 1/1000 dilution) hyperimmune
for MV and cross reactive with other morbilliviruses; Mouse anti-
SLAM (5C6) anti-CD46 (13/42) monoclonals, obtained from J.
Schneider–Schaulies, (both antibodies diluted1/1000) or alterna-
tively mouse anti-SLAM (IPO-3, Research diagnostics Inc, USA,
1/1000) or mouse anti-CD46 (Abcam, 1/500 dilution); goat anti
HB-EGF (Abcam, 1/500). Mouse isotype IgG1 (Abcam, 1/100) or
normal goat serum Abcam, I/500) were used as appropriate
controls. All secondary antibodies were diluted in PBS and cover
slips washed and incubated for 1 hr at 37uC with the appropriate
FITC-conjugate: rabbit anti-human IgG (Abcam, 1/50); rabbit
anti-mouse (DAKO A/S, Denmark, I/100) or donkey anti-goat
(Abcam, 1/100). The coverslips were then mounted in vectashield
mounting medium with DAPI (Vector Laboratories) or propidium
iodide (Abcam). In each experiment controls consisting of non-
infected cells and coverslips treated with appropriate control
serum instead of primary antibody were included. Images were
examined using a BioRad Microradiance Confocal Olympus
BX60 epifluorescent or a UV Eclipse TE2000-U (Nikon)
microscope.
Receptor blocking assay
Cells were treated with 10mg/ml of appropriate antibodies or
control serum in the appropriate medium and incubated at 37uC
for 1 h prior to the addition of virus at an MOI of 0.1. Further
incubation was carried out for selected times in the presence of the
antibody.
Receptor Binding Assay
Monolayers were treated with virus at an MOI of 10 at 4uC and
washed 3 times with PBS. RNA was extracted using TriZol
reagent (Sigma). Sybr green qRT-PCR was carried out using a
qRT-PCR system from Alignment Technology in a 7500 Teal
Time PCR system (Applied Biosystems). The copy number for
virus RNA was determined from a standard curve. MV P gene
and b actin primers and the assay conditions were previously
described [43]. The PDV Phosphoprotein (P) gene primers
sequences used were:-
Forward 59 CCA TTA AAA AGG GCA CAG GA
Reverse 59 GTT TCT CGG GTT GGG GTC TCG TA
Flow cytometry analysis
Staining for flow cytometry was carried out according to the BD
Cytofix/Cytoperm Fixation/Permeablization Kit manufacturer’s
instructions (BD, UK). Cells were washed 3 times in PBS and
16105 cells suspended in 1/100 dilution of SSPE serum,
incubated at 37uC for 1 h, washed and incubated with FITC-
conjugated rabbit anti-human IgG (1/50 dilution) at 37uC for 1 h.
Cells were washed and resuspended in PBS with 1% FCS. The
samples were examined in a (PartecCyFlow Space) and analyzed
by a FlowJo programme (Oregon, USA). Experiments were
repeated at least three times.
Statistical analysis
Statistical analysis was carried out by using the student T-test.
Values of p,0.05 were considered statistically significant*,p,0.01
very significant ** and ,0.001 highly significant ***.
Results
wtPDV infects Vero cells
To determine if PDV uses SLAM as a receptor we infected
Vero and VDS cells at an MOI of 0.1 with wtPDV/NL88n, wt
PDV/USA2006, wtCDV and wtMV. Large syncytia formation
was first observed in VDS cells infected with all viruses at 1 dpi
with the monolayer completely fused by 2 days post infection (dpi)
(Figure 1A top panel) and disintegration after 3 days. Also as
expected wtMV failed to produce CPE in Vero cells while a few
isolated rounded cells were noted in wtCDV infected cultures at
2 dpi. However, in contrast both wtPDV strains produced
extensive cell rounding at 2 dpi (Figure 1A bottom panel). To
verify that the cell rounding was caused by the virus, immuno-
fluorescence staining of PDV/NL88n, wtCDV and wtMV
inoculated cultures using SSPE antiserum (which cross-reacts with
all morbilliviruses) was carried out. In wt PDV cultures the
rounded cells observed were found to contain virus at 2 dpi with
more extensive infection by 5 dpi when a limited amount of fusion
occurred. A single foci of infection is shown for wtCDV at 5 days
dpi while no antigen was detected in wtMV cultures (Figure 1B).
Further Vero and VDS cultures were infected at an MOI of 0.1
with wtPDV/NL88n, WTPDV/USA2006 wtMV and wtCDV
and total virus yields (determined by titration on VDS cells) were
compared from 1 to 5 dpi. The virus titres obtained were not
significantly different at 2 dpi between Vero and VDS cells. Due
to total destruction of the monolayers in VDS cells by 3dpi further
titres could not be determined. In contrast, the titre in Vero cells
Table 1. Cell lines and Known Receptors for Morbilliviruses.
Cell Type Known Morbillivirus Receptors
Vero African Green Monkey Kidney CD46 (vaccine strains of MV, not wtMV or CDV)
Vero-dogSLAM (VDS) Vero-stably transfected with canine SLAM CD46, SLAM
B95a Adherent Marmoset B cell –Epstein Barr virus-transformed SLAM (MV, CDV, RPV), non-functional CD46
CHO Chinese hamster ovary None
CHO-CD46 CHO stably transfected wth human CD46 MV vaccine strains
CHO-dogSLAM CHO-stably transfected with canine SLAM SLAM (MV,CDV, RPV)
CHO-MSLAM CHO-stably transfected with marmoset SLAM SLAM (MV, CDV, RPV)
CHO-PVRL4 CHO-stably transfected with human PVRL-4 PVRL4 (MV)
CHO-proHB-EGF CHO-stably transfected with human proHB-EGF Unknown
CHO-Empty Stably transfected with empty plasmid None
doi:10.1371/journal.pone.0106281.t001
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substantially increased by 5 dpi indicating prolonged production
of virus. WTMV and wtCDV strains showed no and minimal
virus growth, respectively (Figure1C). Altogether, these results
indicated that SLAM expression is dispensable for the entry of
wtPDV in Vero cells.
Infection of Vero Cells by wtPDV is not dependent on
CD46
As wtPDV could infect Vero cells in the absence of SLAM, we
examined the use of CD46 as a receptor for this virus. Since
wtMV and wtCDV strains do not infect Vero cells (Figure 1A and
Figure 1C), a vaccine strain of MV, which uses CD46 as a
receptor in Vero cells, and the Onderstepoort vaccine strain of
CDV, which infects Vero cells in a CD46 independent manner
were used as positive and negative controls, respectively. Vero cells
were treated with anti-CD46 antibody for 1 h and infected at an
MOI of 0.1 with wtPDV/USA2006 (for 5 days), Schwarz-GFP
MV and CDV Onderstepoort (for 2 days) when the majority of
cells are infected in isotype control treated cultures. Infected and
mock infected cells were fixed, stained with SSPE serum (with the
exception of Schwarz-GFP MV) and flow cytometry carried out
for all three viruses. In parallel, virus was harvested from MV (at 2
days) and PDV (at 5 days) infected cultures and titres determined
by TCID50. As expected GFP production was significantly
reduced in cells treated with anti-CD46 antibody and infected
with Schwarz-GFP MV. The single peak of fluorescence indicates
that cells have a continuous range of GFP expression, the majority
with no expression and those in the tail of the peak with levels
equivalent to cells treated with the isotype serum control. Anti-
CD46 antiserum had no effect on CDV or wtPDV antigen
production (Figure 2A) while the MV virus titre was reduced by 2
logs (Figure 2B). Therefore, these results exclude the use of CD46
as a receptor for PDV.
Infection of B95a cells with wtPDV is partially inhibited by
anti-SLAM antibody
Cell fusion but not wtPDV replication was increased in VDS
compared to Vero cells. Therefore, the role of SLAM as a cell
entry receptor was further examined in B95a cells. Cells were
treated with anti-SLAM antibody, infected at an MOI of 0.1 for 2
days with wtPDV/NL88n (previously isolated and grown in B95a
cells), Edmonston MV vaccine, Schwarz-GFP vaccine, wtMV and
wtCDV strains were used as positive controls. Infected and mock
infected cells were fixed, stained with SSPE serum (with the
exception of Schwarz-GFP MV) and flow cytometry carried out
for all four viruses. All strains of MV are known to use SLAM and
infection is inhibited in B95a cells in the presence of anti-SLAM
antibody [44]. Our results confirmed this finding. However, the
degree of inhibition varied between viruses with Schwarz-GFP
MV having the greatest inhibition and wtPDV and wtCDV the
least (Figure 3A). In parallel B95a cultures infected with wtMV,
wtCDV and PDV/NL88n, virus titres were determined by
TCID50 (Figure 3B). These results were in agreement with those
from flow cytometry and show that wtMV, wtCDV and wtPDV
infection was only partially blocked by the anti-SLAM antibody.
SLAM and PVRL4 expression on CHO cells increases
infection of wtPDV
The results suggest that wtPDV is able to use an alternative
receptor to CD46 in Vero cells. We therefore further investigated
the use of SLAM as well as the more newly recognised MV and
CDV receptor PVRL4 using CHO and receptor expressing CHO
cell lines (CD46, PVRL4, MSLAM and DSLAM). CHO cells are
not susceptible to infection by MV strains and do not express
CD46, SLAM or PVRL4. An alignment using sequences available
in GenBank for canine (NP001003084) and phocine (BAH10672)
SLAM amino acid sequences show 83% identity overall and 100%
at the SLAM binding site [45] validating the use of CHO-DSLAM
cells. The expression of CD46, SLAM and PVRL4 was initially
confirmed on the respective CHO cell lines by staining, non-
permeabilised cells with the appropriate receptor antibody or
isotype control. Cultures stained with control antibody showed no
staining (not shown) as did CHO cells stained with any of the
receptor antibodies, as illustrated for anti-CD46 antibody
(Figure 4A). All CHO cell lines and VDS cells (as positive control)
were infected for 2 days at an MOI of 0.1 with selected wt viruses.
Cells were fixed, permeabilised and incubated with SSPE serum.
Only 0 to 2% of cells (in 10 fields of view) expressed antigen in
both CHO and CHO-CD46 cells infected with wtPDV/NL88n or
wtPDV/USA2006. In contrast the majority of CHO-MSLAM
cells were infected throughout the monolayer with these PDV
strains (Figure 4B). CHO-DSLAM and, CHO-PVRL4 cells
showed infection with wtPDV/USA2006, wtMV and wtCDV
(Figure 4C, top and middle panels). However infection was focal
in nature compared to VDS cells (Figure 4C, bottom panel) where
large syncytia were observed.
Cultures of all CHO cell lines were infected at an MOI of 0.1
for 1 to 5 days with wtPDV/USA2006. CHO, CHO-DSLAM and
CHO-PVRL4 cells were also infected with wtCDV. Titres were
determined in VDS cells by TCID50. Approximately a 2 fold
increase in titre was achieved in CHO-MSLAM and/or CHO-
DSLAM and CHO-PVRL4 compared to CHO cells for both
viruses (Figure 5). However, the titre in these cell lines was 1 to 2
logs lower than those obtained in either VDS or Vero cells
(compare Figure 1C and Figure 5) suggesting a restriction in
replication and virus maturation in CHO cell lines in general.
Table 2. Virus Origin and Isolation.
Virus Origin Cell line of Isolation and growth
wtPDV/NL88n Isolated in 2003 from blood of seal from 1988 Netherlands
outbreak
B95a
wtPDV/USA2006 Isolated from seal, east coast of USA 2006 VDS
wtCDV Snyder Hill Isolated from dog, Ithaca, NY, USA- early 1970’s Isolated in dog lung macrophages and 2 passages in VDS cells
MV Edmonston Measles vaccine strain Continual passage in Vero cells
MV Schwarz GFP Measles recombinant vaccine strain expressing GFP Continual passage in Vero cells
CDV Onderstepoot CDV vaccine strain Continual passage in Vero cells
doi:10.1371/journal.pone.0106281.t002
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Figure 1. wtPDV infects Vero cells. Vero and VDS cells were infected at an MOI of 0.1. (A) CPE observed in Vero and VDS cultures infected with
wtPDV/NL88n, wt PDV/USA2006, wtCDV and wtMV at 2 dpi by phase contrast microscopy (Magnification X100). Foci of rounded cells are indicated
by arrows. (B) Cells were infected with wtPDV/NL88n, wtCDV and wtMV, fixed, permeabilised and stained with SSPE serum and rabbit anti-human
FITC; nuclei were stained with propidium iodide. Images were taken using a Nikon Eclipse TE2000-U UV microscope (x400). (C) Vero cells and VDS
cells were infected with wtPDV/NL88n, wtPDVUSA2006, wtMV and wtCDV for up to 5 days. Titres were determined by TCID50 in VDS cells. The results
are representative of two independent experiments.
doi:10.1371/journal.pone.0106281.g001
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Figure 2. Infection of Vero cells by wtPDV is not dependent on CD46. Vero cells were incubated with anti-CD46 monoclonal antibody or
mouse isotype control prior to virus infection (MOI 0.1) for 2 days (Schwarz-GFP MV and Onderstepoort CDV) or 5 days (wtPDV/USA2006). (A) Mock
infected and infected cells were fixed before staining (with the exception of Schwarz-GFP MV) with SSPE serum followed by rabbit anti-human FITC
and analysed by flow cytometry. (B) Virus was harvested from cells infected with wtMV and wtPDV and titres determined by TCID50 in VDS cells. The
results are representative of two independent experiments.
doi:10.1371/journal.pone.0106281.g002
Cell Entry Receptors for Wild Type Phocine Distemper Virus
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Overall the results indicate that wtPDV uses both SLAM and
PVRL4 as receptors.
Virus Infection of Vero cells is not inhibited by disruption
of GAG chain sulfation or heparinase treatment
As we had determined that both wt strains of PDV could infect
Vero cells in a CD46 and SLAM independent manner, the
receptor usage in these cells was further investigated. Glycosami-
noglycans (GAG) have been implicated as a receptor/or to
enhance receptor binding of some RPV, CDV and MV strains
[15,39,40]. We therefore examined the effect on PDV and MV
infection of disruption of GAG chain sulfation in Vero cells by
using the potent inhibitor of this process, sodium chlorate. Vero
cells were treated with either 30 or 60 mM sodium chlorate for 2
days or left untreated prior to infection. Triplicate cultures were
infected at an MOI of 0.1 with Schwarz GFP MV or wtPDV/
USA2006. CPE was monitored for 2 days for MV and 5 days for
wtPDV. Coverslip cultures used for PDV infection were fixed,
permeabilised and stained at the end of the experiment for virus as
before. MV syncytia in both the 30 mM and 60 mM sodium
Figure 3. Infection of B95a cells with wtPDV is partially inhibited by anti-SLAM antibody. B95a cells were incubated with anti-SLAM
monoclonal antibody or mouse isotype control prior to infection at an MOI of 0.1 with (A) Edmonston MV, Schwarz GFP MV, wtCDV and wtPDV/
NL88n at MOI of 0.1 for 2 days followed by fixation and staining (with the exception of Schwarz-GFP MV) with SSPE serum followed by rabbit anti-
human FITC and analysed by flow cytometry. (B) Virus was harvested from cells infected with wtMV, wtCDV and wtPDV/NL88n and determination of
titres by TCID50 in VDS cells. The results are representative of two independent experiments.
doi:10.1371/journal.pone.0106281.g003
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Figure 4. Increased infection of wtPDV infection in CHO cells expressing either SLAM or PVRL4. (A) CHO-CD46, CHO-MSLAM and CHO-
PVRL4 cells were stained with their respective receptor antibodies or mouse isotype control, fixed and stained with rabbit anti-mouse FITC. CHO cells
were stained in the same manner with anti-CD46 antibody (B) CHO, CHO-CD46, and CHO-MSLAM cells were infected with wtPDV/NL88n and
wtCDVUSA2006 (C) CHO, CHO-DSLAM, CHO-PVRL4 and VDS cells with wtPDV/USA2006, wtCDV and wtMV at MOI of 0.1 for 2 days. Cells were,
permeabilised, fixed and stained with SSPE serum followed by rabbit anti-human FITC. Nuclei were either stained with propidium iodide and images
take in a Leica TCS/NT confocal microscope or stained with DAPI and images taken using a Nikon Eclipse TE2000-U UV microscope (x400).
doi:10.1371/journal.pone.0106281.g004
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chlorate treated monolayers were smaller in size compared to
control cultures. In wtPDV infected cultures sodium chlorate
treatment reduced the limited degree of fusion with this virus
further (Figure 6A). Cell free virus was harvested from each well of
both MV and wtPDV infected cultures at the end of the sodium
chlorate experiment and TCID50 titrations carried out. No
significant difference in titre was found between untreated and
sodium chlorate treated cultures (not shown). Cultures were also
treated with 10 U/ml of heparinase for 90 min and infected at an
MOI of 0.1 with Schwarz GFP-MV or PDV/NL88n and CPE
monitored as before. While, untreated Schwarz GFP-MV infected
cultures showed extensive fusion and GFP expression throughout
the monolayer, heparinase treated cultures had localised plaques
of GFP expression with little fusion. Similarly, untreated wtPDV
infected monolayers had extensive rounded cell formation with
some fusion while heparinise treated cultures displayed reduced
fusion (indicated by red arrows) (Figure 6B). These results indicate
that fusion activity rather than virus yield is affected by removal or
disruption of GAG.
Treatment of Vero cells with anti-b1 integrins enhances
infection of wtPDV and MV
The results indicated use of an additional receptor to SLAM on
B95a cells as well as a receptor other than CD46 on Vero cells for
wtPDV. We therefore investigated 2 candidate molecules which
are in the same tetraspan complex with CD46 and CD9. Most
tetraspan molecules co-preciptate with b1 integrins and these have
been identified as receptors for a number of viruses [46]. As
expected we found that Vero cells showed good expression of b1
integrin (Figure 7A). We therefore examined the effect of anti-b1
integrin blocking antibody on infection of Vero cells with
wtPDVUSA/2006, the Edmonston strain of MV and CDV
Onderstepoort. Cells were infected at an MOI of 0.1 and stained
for virus antigen as before at 2 dpi for MV and 5 days for wtPDV,
followed by flow cytometry. Parallel cultures were infected in the
Figure 5. Increased titres of wtPDV are obtained in CHO cells expressing either SLAM or PVRL4. Cells were infected (MOI of 0.1) with
wtPDV/USA2006 (all CHO cell lines) and wtCDV (CHO, CHO-DSLAM and CHO-PVRL4). Virus was harvested at 1 to 5 dpi from wtPDV and wtCDV
infected cultures and the titre determined by TCID50 in VDS cells. The results are representative of two independent experiments.
doi:10.1371/journal.pone.0106281.g005
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same manner and virus titres determined. CDV infection was not
affected by anti- b1 integrin treatment. Rather than inhibition there
was a marked increase in both Edmonston MV and wtPDV antigen
expression (Figure 7B) and infectivity levels (Figure 7C) in anti-b1
integrin treated cells. This suggested that the anti-integrin antibody
was enhancing rather than blocking infection of these viruses.
Treatment of Vero cells with anti HB-EGF antibody
reduces infection of PDV
It has been previously shown that proHB-EGF (like CD46)
forms a complex with CD9 and integrin alpha3beta1 in Vero cells
[34,35]. We therefore investigated whether this molecule could be
a possible receptor for wtPDV/USA. Edmonston MV (which uses
CD46) and CDV Onderstepoort (which infects Vero using an
unknown receptor) were used for comparison. Cells were treated
with anti-HB-EGF antibody or control goat serum, infected at an
MOI of 0.1 and examined by phase contrast microscopy at 2 (MV
and CDV) or 5 (wtPDV/USA2006) dpi. All cultures treated with
control non-immune goat serum showed extensive CPE with all 3
viruses. As expected no inhibition of infection was observed with
MV and/or CDV cultures treated with anti-HB-EGF serum.
However, in wtPDV infected cultures only a few rounded cell foci
Figure 6. Sodium chlorate and heparinase treatment decreases cell fusion. Vero cells were untreated or treated with 30 mM or 60 mM
sodium chlorate for 2 days prior to infection (MOI 0.1) with Schwarz-GFP MV or wtPDV/USA2006. (A) CPE and GFP expression by Schwarz-GFP MV was
examined at 2 days by dual phase contrast-UV microscopy (top panel). Cultures of wtPDV were fixed and permeablised at 5 dpi before staining with
SSPE antibody and rabbit anti-human FITC (bottom panel). Nuclei were stained with DAPI. (B) Vero cells were treated with 10 U/ml of heparinase for
90 min and infected at an MOI of 0.1 with Schwarz GFP MV or wtPDV/NL88n. CPE was examined at 2 days by dual phase contrast-UV microscopy (top
panel) and wtPDV CPE by phase contrast microscopy (bottom panel). Images were taken using a Nikon Eclipse TE2000-U UV microscope (X100).
doi:10.1371/journal.pone.0106281.g006
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Figure 7. Anti-b1 integrin treatment of Vero cells increases infection of wtPDV and Edmonston MV. (A) Vero cells were examined for b1
integrin expression by staining cells with anti-b1 integrin antibody or mouse isotype control followed by fixation and staining with rabbit anti-mouse
FITC. Nuclei were stained with DAPI. Immunofluorescent images were taken using a Nikon Eclipse TE2000-U UV microscope (x100). (B) and (C) Vero
cells were incubated with anti-b1 integrin (blocking) antibody or with control mouse isotype, prior to infection (MOI 0.1) for 2 days (Onderstepoort
CDV and Edmonston MV) or 5 days (wtPDV/USA2006). (B) Cells were fixed before incubating with SSPE serum followed by staining with rabbit anti-
human FITC and analysed by flow cytometry. (C) Virus was harvested and the titre determined by TCID50/ml in VDS cells. The results are
representative of two independent experiments.
doi:10.1371/journal.pone.0106281.g007
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were observed at 5 dpi with anti-HB-EGF treatment compared to
extensive cell rounding with some fusion in control goat serum
treated cultures (Figure 8A). Cultures were fixed, stained for virus
antigen as before and flow cytometry carried out. Reduction in
virus antigen was very marked for wtPDV but did not occur for
MV or CDV (Figure 8B). Virus titres were determined in parallel
cultures also infected at an MOI of 0.1. The titre of wtPDV was
reduced by approximately 2 logs in anti-HB-EGF treated cultures
while MV and CDV were not affected (Figure 8C). This suggests
that proHB-EGF may either act as a cell entry receptor for wtPDV
or that treatment of cells with the antibody reduces efficiency of
virus replication.
PDV infection and binding is increased in CHO-proHB-
EGF cells
To examine further if the membrane anchored form of HB-
EGF (proHB-EGF) is used as a receptor for wtPDV infection, a
transfected CHO cell line was used. The expression of human
proHB-EGF was initially assessed on CHO-empty (CHO-E) and
CHO-pro-HB-EGF non-permeabilised cells. CHOE cells carry
the control plasmid used to express proHB-EGF and showed no
staining as expected while proHB-EGF cells showed expression of
the molecule (Figure 9A). CHO-E and CHOpro-HB-EGF cells
were inoculated at an MOI of 0.1 with wtPDV/USA2006,
wtPDV/NL88n, wtCDV and wtMV (as negative controls) and
cultures examined at 2dpi. CHOE cells infected with wtMV and
wtCDV (not shown) or wtPDV strains (illustrated for wt PDV/
USA2006, Figure 9B, first panel) showed no CPE as did wtMV
and wtCDV CHO-pro-HB-EGF inoculated cultures (not shown).
However, wtPDV inoculated CHO-proHB-EGF cultures showed
cell rounding and areas with limited fusion (illustrated for PDV/
USA2006, Figure 9B, first panel). Cells were fixed in paraformal-
dehyde, permeabilised and stained with anti-SSPE serum and
rabbit anti-human FITC. In both CHO-E and CHO-proHB-EGF
cells no staining was seen for wtMV or wtCDV (Figure 9B, 2nd
and 3rd panesl). However, extensive staining, showing areas of
fusion was observed in wtPDV infected cells. In contrast a few cells
in CHO-E cultures showed pin point inclusions (Fig 9B, 4th and
5th panels).
We also compared binding at 4uC of wtPDV/USA2006,
wtCDV and wtMV to CHO-E and CHO-proHB-EGF cells
treated with sodium chlorate to remove heparin (as this might
interfere with binding). qRT-PCR was used to determine the
relative amounts of virus associated with cell monolayers. In
wtMV and wtCDV treated cultures RNA was below the detection
limit in both CHO cell lines, while over 20 times more wtPDV
RNA copies were detected associated with CHO-proHB-EGF
than CHO-E cultures (Figure 9C). Overall these results indicate
that proHB-EGF is used as a cell entry receptor by wtPDV.
Discussion
We have confirmed that wtPDV uses SLAM as a virus receptor
and that no major differences in virus titre are found between
CHO-MSLAM and CHO-DSLAM cells. It has been determined
that only one amino acid change in the H protein of CDV allows
the virus to adapt to human SLAM [47]. Furthermore, the SLAM
virus H binding site [48] is conserved between canine and phocine
SLAM species indicating that titres are likely to be similar in cells
expressing the latter. We did not find any significant differences
between use of canine and marmoset SLAM by PDV. Tatsuo et al
[14] found that MV, CDV and rinderpest virus used their species
specific SLAMs more efficiently. This may be dependent on the
viruses used and their passage histories.
The sequence of phocine PVRL4 has not been published and is
not found in Genbank. However, canine PVRL4 shares 94%
identity with the human sequence. Therefore, members of the
carnivore, i.e. seal and dog sequences would be predicted to have
even higher similarity. Furthermore, morbilliviruses have been
shown to bind to the V domain of PVRL4 [49] with the virus H
protein binding site being highly conserved. This would explain
why wtPDV can readily use human PVRL4 and suggests that the
virus could also use this molecule in vivo.
Unlike wt MV and wtCDV, wt strains of PDV were found to
infect Vero cells with no prior adaptation. In common with RPV
and CDV [30,31] we have demonstrated that wtPDV does not
utilise CD46 as a receptor. These results further support the
presence of another receptor for wtPDV which we have identified
as proHB-EGF on Vero cells. This molecule is also expressed on
EBV transformed B cells [50] and may therefore explain why
infection of wtPDV was only slightly reduced by anti-SLAM
antibody treatment of B95a cells. However, wtCDV infection of
B95A cells was also only slightly reduced and may indicate a
further unknown receptor(s) on these cells for morbilliviruses.
The number of proHB-EGF molecules on the surface of Vero
cells is at least 100-fold less than CD9 molecules [35]. The low
density of the receptor may result in relatively reduced virus entry
and slower virus spread which would explain why 5 days are
required to get good infection levels of wtPDV and limited fusion
occurs in Vero compared to VDS cells. wtCDV showed little or no
infection of Vero cells and anti HB-EGF antibody did not inhibit
infection by the Onderstepoort stain of CDV which infects these
cells giving extensive cell fusion after 2 days in a similar manner to
vaccine strains of MV. The Onderstepoort virus is therefore likely
to use an unknown high density receptor in Vero but it cannot be
ruled out that proHB-EGF could also be utilised. ProHB-EGF has
been identified as the diphtheria toxin (DT) receptor [35] and
although the phocine sequence is unknown other members of the
carnivore show 89% identity with the human and monkey amino
acid sequence. Furthermore, juxtamembrane and transmembrane
domains, as well as a proposed heparin-binding region are highly
conserved across these species [51] which would explain the lack of
adaption required by wtPDV to use the receptor in Vero cells.
Although proHB-EGF is expressed in all mammalian species
examined to date, species differences in the DT binding site and
hence sensitivity to this toxin occur. Vero cells are extremely
sensitive to DT whereas mouse and rat cells are resistant. Hamster
cells demonstrate intermediate sensitivity [52]. Our results show
that wtPDV can bind 20 times more efficiently to Vero than to
CHO cells, suggesting that the virus may be binding to the DT
binding site but this will require investigation. It has been reported
that gut epithelium is extensively infected by PDV in harbour seals
[53] whereas in experimental CDV infection of this species the
evidence for infection in epithelial is inconclusive [54]. This could
Figure 8. Treatment of Vero cells with anti-HB-EGF reduces infection of wtPDV. (A) and (B) Vero cells were treated with anti-HB-EGF or goat
non-immune control serum, prior to infection (MOI 0.1) for 2 days (Edmonston MV and Onderstepoort CDV) or 5 days (wtPDV/USA2006). (A) Cells
were examined by phase contrast microscopy and images taken using a Nikon Eclipse TE2000-U UV microscope (x400). (B) Cells were fixed before
incubating with SSPE serum followed by staining with rabbit anti-human FITC and analysis by flow cytometry. (C) Virus was harvested from infected
cultures and titres determined by TCID50. The results are representative of two independent experiments.
doi:10.1371/journal.pone.0106281.g008
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Figure 9. wtPDV infection and binding is increased in CHO-proHB-EGF cells. CHO-empty and CHO-proHB-EGF cells were (A) examined for
pro-HB-EGF expression by staining with goat anti-HB-EGF antibody or control goat serum followed by fixation and staining with rabbit anti-goat FITC.
(B) Inoculated with wtPDV/USA2006, wtPDV/NL88n, wtCDV or wtMV (MOI 0.1) for 2 days. Cells were viewed by phase contrast microscopy (1st panel)
or fixed before staining with SSPE serum and rabbit anti-human FITC (all other panels). Images were taken using a Nikon Eclipse TE2000-U UV
microscope (X400). (C) Monolayers were inoculated with wtPDV/USA2006, wtCDV or wtMV (MOI 10) at 4uC for 2 hr. After washing, Sybr green qRT-
PCR was carried out and the copy number of virus RNA determined from a standard curve.
doi:10.1371/journal.pone.0106281.g009
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be explained by the ability of PDV but not CDV to ustilise
phocine proHB-EGF.
Vero cell infection was not inhibited in the presence of an
integrin b1 function blocking antibody. In contrast, surprisingly
MV and PDV infection was enhanced. Antibody to b1 integrins
was previously reported to have no effect on fusion activity of MV
in Hela cells. However, viral antigen/infectivity levels were not
examined [33]. Antibodies to members of the tetraspans have been
found to inhibit or enhance cell fusion depending on the virus, due
to either physical separation of the virus fusion machinery from
cell-cell contact areas or to inclusion of viral envelope proteins in
the tetraspan complex [55]. Furthermore, permissiveness of
macrophages to MV using CD46 as a receptor is increased with
formation of a complex of CD9, b1 integrins and CD46 [33]. It is
therefore possible that anti-b1 integrin treatment is enhancing
complex formation in a similar way in the Vero cell membrane
allowing closer contact of MV and PDV H and F proteins with
CD46 and proHB-EGF, respectively. It will be necessary to
examine a range of integrin b1 function blocking antibodies to
determine if they increase rather than reduce infection.
ProHB-EGF is also a heparin binding molecule and binding to
heparin could enhance infection. Heparinase and sodium chlorate
treatments of Vero cells had no effect on released virus titre.
However, inhibition of fusion occurred in treated cultures. The
effect was less apparent in wtPDV infected cultures due to the
more limited level of fusion compared to MV even in untreated
cultures. We propose that binding of PDV to heparin or heparin-
like molecules associated with proHB-EGF would enhance F
protein interaction with the cell membrane but this will require
further investigation.
In conclusion, we have confirmed that SLAM is used as a
receptor by wtPDV and that the virus does not utilise CD46.The
results also indicate that PVRL4 is also used as a receptor in
common with MV, CDV and PPRV. This common second
receptor may further increase the probability of cross species
infection. The finding that wtPDV can use proHB-EGF as a low
density receptor in Vero cells indicates that the binding site in the
wtPDV H protein requires no or minimal change to utilise this
receptor. It remains to be determined if this receptor has a role
during PDV infection in the natural host but the lack of adaption
required to infect Vero cells and the high conservation of the
transmembrane sequence suggests that this is likely to be the case.
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